Skip to content
Our Company
Culture and Values
Leadership
Corporate Impact
Environmental, Social, and Governance
Product Donations
Charitable Giving
CME and Research Grants
Careers
Open Roles
Life at Emergent
Locations
Our Focus
Biological Threats
Opioid Crisis
Manufacturing Partnerships
Our Science
Pipeline
Publications
Our Products
Product and Medical Inquiries
Latest
Press Releases
Blog
Podcast
Media Statements
Media Resources
Investors
FOLLOW US
All Publications
Filter:
Program
Medical Countermeasures
Opioid Antagonist
Filter
August 10, 2026
ACAM2000 Vaccine Safety and Immunogenicity Considerations for Smallpox and Mpox
Read More
July 19, 2026
A Phase 1, Open-Label, Randomized Study to Investigate the Pharmacokinetics and Safety of Multiple Doses of Intranasal Naloxone in Healthy Participants
Read More
April 1, 2026
Improving Inferences Regarding Patient Events Using Emergency Medical Services Response-Based Data
Read More
March 10, 2026
Lack of Resistance Development During Brincidofovir Therapy in Animal Models of Orthopoxvirus Infection
Read More
January 31, 2026
A Phase 4, Open-Label, Single Arm, Multi-Center Study to Evaluate the Safety of a Smallpox Vaccine in Previously Vaccinated Individuals
Read More
December 24, 2025
Effect of Co-administration of the Anthrax Vaccine Adsorbed, Adjuvanted with Ciprofloxacin or Doxycycline on Antibiotic Pharmacokinetics and the Vaccine Immunogenicity: A Phase 2 Drug-Vaccine Interaction Study
Read More
December 15, 2025
Immunogenicity, Safety, and Lot Consistency of the Anthrax Vaccine Adsorbed, Adjuvanted for Post-Exposure Prophylaxis of Anthrax in Healthy Adults: A Phase 3, Randomized, Double-Blind Trial
Read More
July 20, 2025
Brincidofovir in the Era of Mpox
Read More
March 1, 2025
A Healthy Participant Study to Evaluate the Bioequivalence of Form H and Form II Tablets of the Smallpox Antiviral Brincidofovir (BCV)
Read More
May 20, 2024
Underreporting or Failed Notification? Global Botulism Reporting, 2000-2022
Read More
May 10, 2024
Naloxone Distribution Programs in the Emergency Department: A Scoping Review of the Literature
Read More
February 14, 2024
Compatible Co-administration of BioThrax® Vaccine and Ciprofloxacin-Results of a Randomized Open-Label Drug-Vaccine Interaction Trial
Read More
1
2
3
4
